Maharaj Nakorn Chiangmai Hospital; Department of Surgery/ Urology unit

Chiang Mai 50200

0 studies enrolling now · 2 studies all time

What they study most

Renal Cell Carcinoma

Studies at this site

• A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy — Stopped early
• A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC) — Completed